Ces radiol. 2011, 65(4):272-278

Comparison of women's mortality of breast cancer identified in the screening and diagnostic examinationsOriginal article

Alena Bílková1, Marie Zemanová1, Václav Janík1, Jana Vránová2
1 Radiodiagnostická klinika 3. LF UK a FNKV
2 Ústav lékařské biofyziky a lékařské informatiky 3. LF UK

Introduction: Breast cancer is the most frequently diagnosed major cancer among women. In the Czech Republic it is found in 20% of women suffering with cancer. Annually, about 5.000 women ill with breast cancer and around 1900 women die. Nationwide breast cancer screening has been introduced in 2002 in Czech Republic and there was expected that it should increase the proportion of lower stage cancers and reduce the mortality of women with breast cancer. The introduction of screening has shown that despite the rising incidence of breast cancer, mortality did not increase, rather stagnated or slightly decreased.

Aim: To evaluate the group of patients with breast cancer identified in the screening and diagnostic examinations, whether screening can reduce the mortality of women of breast cancer.

Method: During the period from January 2003 to December 2009 in the Faculty Hospital Královské Vinohrady in Prague there were total found 476 breast cancers in 466 women. In the screening group of patients diagnosed with breast cancer were enrolled 160 women with 161 breast cancers. One patient had at the time of diagnosis bilateral carcinoma. To the diagnostic group were included 181 women with breast cancer, with a total of 186 tumours. Bilateral breast cancer was diagnosed in 5 women in the period. Mammography, ultrasound and core-cut biopsy from breast tissue were used in all patients with the breast cancer. In both groups of patients was also evaluated the average size of diagnosed tumors and statisticly was evalueted the mortality of breast cancer.

Results: The average size of a malignant tumor in the screening group was 15.3mms and 25.4 mm in the diagnostic group. During more than 7 years of monitoring, 3 women from the screening group (160 women) died of breast cancer. In the diagnostic group (181 women) 13 women died of breast cancer. A comparison of screening and diagnostic group was confirmed statistically significantly lower mortality rate in the screening group than in the diagnostic group.

Conclusion: During more than 7 years old follow up of patients with breast cancer has been shown that breast cancer screening can reduce mortality of breast cancer. Achieved results support the continuation of breast cancer screening program in the Czech Republic.

Keywords: breast cancer, screening and diagnostic mammography, mortality of breast cancer
Grants and funding:

Tato práce byla vytvořena za podpory grantu IGA UP č. LF_2011_007.

Accepted: March 15, 2011; Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bílková A, Zemanová M, Janík V, Vránová J. Comparison of women's mortality of breast cancer identified in the screening and diagnostic examinations. Ces radiol. 2011;65(4):272-278.
Download citation

References

  1. Skovajsová M. Mamodiagnostika - Integrovaný přístup. Praha: Galén 2003.
  2. ÚZIS ČR. Aktuální informace 6/2009. Zhoubné nádory v roce 2006.
  3. Abrahámová J. Karcinom prsu. Postgraduální medicína 2004; 5: 478-498.
  4. ÚZIS ČR. Aktuální informace 6/2009. Zhoubné nádory v roce 2006.
  5. Věstník MZ ČR. Ročník 2010, vydán 26. 3. 2010.
  6. Daneš J. Screening karcinomu prsu, situace a perspektivy v České republice. Actual Gyn 2009; 3: 13-17.
  7. Nyström L, Anderson I, Bjurstam N, Frisek J, et al. Long-term effects of mammography screening update overview of the Swedish randomised trials. The Lancet 2002; 359: 909-919. Go to original source... Go to PubMed...
  8. Keen JD, Keen JE. What is the point: will screening mammography save my life? BMC Medical Informatics and Decision Making 2009; 9: 9-18. Go to original source... Go to PubMed...
  9. Skovajsová M, Svobodník A. Přínos a rezervy screeningu nádoru prsu v ČR. Onkologická péče 2007; 1: 1-5.
  10. Crane K. Women in their Forties Have Lower Mammographic Tumor Detectability. Journal of National Cancer Institute 2010; 102: 1093. Go to original source...
  11. Cortesi L, Chiuri V, Ruscelli S, et al. Prognosis of screen-detected breast cancers: results of a population based study. BMC Cancer 2006; 6: 6-17. Go to original source... Go to PubMed...
  12. Saphiro S, Coleman EA, Broeders M, Codd M, et al. Breast cancer screening programmes in 22 countries: current policies, administrations et guidelines. International Journal of Epidemiology 1998; 27: 735-742. Go to original source... Go to PubMed...
  13. Bjurstam N, Björneld L, Duffy SW, et al. The Gothenburg Breast Screening Trial. Cancer 1997; 11: 2091-2099. Go to original source...
  14. Jorgensen JJ, Zahl P-H, Gotze PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010; 340: 1241-1246. Go to original source... Go to PubMed...
  15. Gøtzsche PC. On the benefits and harms of screening for breast cancer. International Journal of Epidemiology 2004; 33: 56-64. Go to original source... Go to PubMed...
  16. Olsen AH, Njor SH, Vejborg I, Schwarz W, et al. Breast cancer mortality in Kopenhagen after introduction of mammography screening: Cohort study. British Medical Journal 2005; 530: 220-224. Go to original source... Go to PubMed...
  17. Heneghan HM, Richard RS, Devaney A, et al. Evolution of breast cancer management in Ireland: a decade of change. BMC Surgery 2009; 18: 9-5. Go to original source... Go to PubMed...
  18. Perry N, Broeders M, Wolf de C, Törngerg S, et al. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition. © European Communities, 409 s.; ISBN 92-79-01258-4.
  19. Soerjomataram I, Lowman MWJ, Ribot JG, et al. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008; 107: 330. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.